U.S. DOE awards Dynasil 7 Phase-II SBIR grants totaling $6.2 million

NewsGuard 100/100 Score

Dynasil Corporation of America (OTCBB:DYSL) today announced that the U.S. Department of Energy (DOE) has approved seven of its Phase-II SBIR projects for awards, ranging from $750,000 to $1,000,000 each. The awards, totaling $6.2 million, are being made to its wholly owned subsidiary, Radiation Monitoring Devices, Inc ("RMD"), to develop its state of the art nuclear sensors and instruments.

“We're especially pleased that the work aligns well and leverages our state of the art discoveries with our development capabilities, to deliver compelling new commercial products for nuclear and X-ray detection for Homeland Security and medical imaging applications.”

Three of the awards are from the DOE's Office of Biological and Environmental Research and focus on developing high resolution imaging detectors for the next generation of nuclear medicine research and medical diagnostic equipment. The radiation detector technologies being developed could also have a major impact in nuclear weapons detection for homeland defense, as well as new instrumentation for oil exploration, scientific studies, and industrial applications.

Additionally, four awards provided by the DOE's Office of Basic Energy Sciences will fund RMD's research on sensor technologies to support the research efforts of scientists working at the DOE's National Laboratories in materials science, nuclear physics and high energy physics. The projects include the development of the next generation of sensors for nanoscale microscopy, as well as new detectors based on nano-particles for ultra-fast high performance X-ray detectors. These materials also have potential commercial applications in many fields including scientific research, renewable energy, cancer detection, environmental clean-up and baggage scanning.

"We are pleased with these awards and with our continued progress in advancing our cutting edge sensor and detector technologies," said Craig T. Dunham, Dynasil CEO. "We're especially pleased that the work aligns well and leverages our state of the art discoveries with our development capabilities, to deliver compelling new commercial products for nuclear and X-ray detection for Homeland Security and medical imaging applications."

"All of these projects are being conducted in collaboration with world class researchers at national laboratories and universities," added Michael Squillante, RMD VP of Research. "In these initiatives, both the DOE and Dynasil are working in tandem towards common technological goals, as well as to deliver compelling new products that Dynasil can commercialize."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Feeling lonely? It may affect how your brain reacts to food, new research suggests